Medpace Holdings, Inc. (MEDP) vs State Street SPDR S&P 500 ETF (SPY)

Over the past 5 years, MEDP outperformed SPY — 27.11% vs 13.33% annualized total return (price plus dividends).

A side-by-side comparison of Medpace Holdings, Inc. and State Street SPDR S&P 500 ETF across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 10, 2026. Differences are shown without an overall score or investment verdict.

Compare
Different business models: MEDP is classified in Healthcare; SPY is classified in Financial Services. Margin, capital intensity, and valuation differences should be interpreted in that sector context.

Total returnMEDP vs SPY

growth of $100 · dividends reinvested · last 10y
MEDP +2025.5% (+35.8%/yr)SPY +319.8% (+15.4%/yr)MEDP compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$2,125$420
MEDP SPY

Metrics side by side

Did MEDP beat SPY?

Over the past 5 years, MEDP outperformed SPY — 27.11% vs 13.33% annualized total return (price plus dividends).

Total return (annualized)

MetricMEDPSPY
Total return (1Y)37.78%23.67%
Total return CAGR (3Y)31.39%21.21%
Total return CAGR (5Y)27.11%13.33%
Total return CAGR (10Y)N/A15.32%

SPY is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Frequently asked

Has MEDP beaten SPY?
Over the past 5 years, MEDP outperformed SPY — 27.11% vs 13.33% annualized total return (price plus dividends).

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 10, 2026.